Natalie Gukasyan

1.7k total citations · 1 hit paper
27 papers, 744 citations indexed

About

Natalie Gukasyan is a scholar working on Clinical Psychology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Natalie Gukasyan has authored 27 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Clinical Psychology, 16 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Natalie Gukasyan's work include Psychedelics and Drug Studies (20 papers), Chemical synthesis and alkaloids (16 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Natalie Gukasyan is often cited by papers focused on Psychedelics and Drug Studies (20 papers), Chemical synthesis and alkaloids (16 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Natalie Gukasyan collaborates with scholars based in United States, United Kingdom and Australia. Natalie Gukasyan's co-authors include Roland R. Griffiths, Sandeep M. Nayak, Frederick S. Barrett, Alan K. Davis, Nathan D. Sepeda, Matthew W. Johnson, Mary P Cosimano, Thomas Cody Swift, David B. Yaden and Eric C. Strain and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Affective Disorders.

In The Last Decade

Natalie Gukasyan

26 papers receiving 729 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

2022 245 citations Natalie Gukasyan, Alan K. Davis et al. Journal of Psychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natalie Gukasyan United States	13	633	412	247	75	75	27	744
Jordan Sloshower United States	8	301 0.5×	208 0.5×	124 0.5×	27 0.4×	48 0.6×	10	348
Kyle T. Greenway Canada	12	209 0.3×	108 0.3×	57 0.2×	77 1.0×	22 0.3×	36	408
Udo Schneider Germany	5	304 0.5×	179 0.4×	168 0.7×	56 0.7×	39 0.5×	8	404
Lindsay A. Lo Canada	8	193 0.3×	97 0.2×	138 0.6×	152 2.0×	6 0.1×	18	348
Michele Gassman United States	8	238 0.4×	141 0.3×	110 0.4×	14 0.2×	27 0.4×	15	317
Dimitri Daldegan‐Bueno Brazil	12	185 0.3×	59 0.1×	67 0.3×	139 1.9×	10 0.1×	34	359
Kevin H. Yang United States	6	129 0.2×	61 0.1×	44 0.2×	90 1.2×	19 0.3×	22	235
Caroline A. MacCallum Canada	9	129 0.2×	34 0.1×	91 0.4×	572 7.6×	14 0.2×	21	689
Ashley Siegel Canada	10	167 0.3×	34 0.1×	39 0.2×	99 1.3×	8 0.1×	17	378
Rhys Ponton New Zealand	10	148 0.2×	59 0.1×	74 0.3×	122 1.6×	4 0.1×	17	325

Countries citing papers authored by Natalie Gukasyan

Since Specialization

Citations

This map shows the geographic impact of Natalie Gukasyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Gukasyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Gukasyan more than expected).

Fields of papers citing papers by Natalie Gukasyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Gukasyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Gukasyan. The network helps show where Natalie Gukasyan may publish in the future.

Co-authorship network of co-authors of Natalie Gukasyan

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Gukasyan. A scholar is included among the top collaborators of Natalie Gukasyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Gukasyan. Natalie Gukasyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lancelotta, Rafael, David I. Quinn, Natalie Gukasyan, et al.. (2025). Exploring Self-Reported Effects of Naturalistic Psychedelic Use Among Gender and Sexual Minorities: A Quantitative Survey Study. Journal of Psychoactive Drugs. 1–14. 2 indexed citations

Wolff, Max, Natalie Gukasyan, Leor Roseman, & Paul Liknaitzky. (2025). Reframing psychedelic regulation: Tools, not treatments. 11. 1 indexed citations

Ching, Terence H. W., Noam Goldway, Natalie Gukasyan, et al.. (2024). Psychedelic medicine in psychiatry residency training: a survey of psychiatric residency program directors. International Review of Psychiatry. 36(8). 902–907. 1 indexed citations

Mathai, David S., et al.. (2024). Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals. Scientific Reports. 14(1). 28022–28022. 7 indexed citations

Lancelotta, Rafael, Nathan D. Sepeda, Natalie Gukasyan, et al.. (2024). The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder. PLoS ONE. 19(3). e0300501–e0300501. 31 indexed citations

Bradberry, Mazdak M., Paul S. Appelbaum, & Natalie Gukasyan. (2024). Informed Consent in Psychedelic-Assisted Therapy. Current topics in behavioral neurosciences. 1 indexed citations

O’Donnell, Kelley C., Terence H. W. Ching, G Glick, et al.. (2023). What Is in a Name? The Many Meanings of “Psychedelic”. PubMed. 1(4). 187–189. 5 indexed citations

Gukasyan, Natalie, Roland R. Griffiths, David B. Yaden, Denis Antoine, & Sandeep M. Nayak. (2023). Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use. Journal of Psychopharmacology. 37(7). 707–716. 29 indexed citations

Gukasyan, Natalie, et al.. (2023). Menstrual Changes and Reversal of Amenorrhea Induced by Classic Psychedelics: A Case Series. Journal of Psychoactive Drugs. 56(1). 50–55. 5 indexed citations

10.

Gukasyan, Natalie. (2023). On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression. Med. 4(1). 8–9. 8 indexed citations

11.

Gukasyan, Natalie, Colleen C. Schreyer, Roland R. Griffiths, & Ángela S. Guarda. (2022). Psychedelic-Assisted Therapy for People with Eating Disorders. Current Psychiatry Reports. 24(12). 767–775. 16 indexed citations

12.

Nikolaidis, Aki, Rafael Lancelotta, Natalie Gukasyan, et al.. (2022). Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms. Journal of Affective Disorders. 324. 239–249. 12 indexed citations

13.

Yaden, David B., Sandeep M. Nayak, Natalie Gukasyan, B. Anderson, & Roland R. Griffiths. (2021). The Potential of Psychedelics for End of Life and Palliative Care. Current topics in behavioral neurosciences. 56. 169–184. 19 indexed citations

14.

Marino, Leslie, et al.. (2021). Psychological Symptoms and Outcomes in Adults Receiving Community-based Treatment for Substance Use Disorders. Substance Use & Misuse. 56(9). 1258–1265. 1 indexed citations

15.

Gukasyan, Natalie & Eric C. Strain. (2020). Relationship between cannabis use frequency and major depressive disorder in adolescents: Findings from the National Survey on Drug Use and Health 2012–2017. Drug and Alcohol Dependence. 208. 107867–107867. 23 indexed citations

16.

Carrico, Adam W., Natalie Gukasyan, Petra Jacobs, et al.. (2020). Problem opioid use and HIV primary care engagement among hospitalized people who use drugs and/or alcohol. Addiction Science & Clinical Practice. 15(1). 19–19. 9 indexed citations

17.

Stitzer, Maxine L., Natalie Gukasyan, Tim Matheson, et al.. (2019). Enhancing patient navigation with contingent financial incentives for substance use abatement in persons with HIV and substance use.. Psychology of Addictive Behaviors. 34(1). 23–30. 8 indexed citations

18.

Kato, Tomoko S., Gerin R. Stevens, Jeffrey Jiang, et al.. (2013). Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation. The Journal of Heart and Lung Transplantation. 32(3). 333–340. 33 indexed citations

19.

Stock, Cameron, Natalie Gukasyan, Ashok Muniappan, Cameron D. Wright, & Douglas J. Mathisen. (2013). Hyperbaric oxygen therapy for the treatment of anastomotic complications after tracheal resection and reconstruction. Journal of Thoracic and Cardiovascular Surgery. 147(3). 1030–1035. 22 indexed citations

20.

Uriel, Nir, Natalie Gukasyan, Daniel B. Sims, et al.. (2011). 192 Psychosocial Evaluation before Left Ventricular Assist Device Implantation Can Predict Device Complication during Support. The Journal of Heart and Lung Transplantation. 30(4). S71–S71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact